InvestorsHub Logo

mcbio

10/28/10 9:33 PM

#107474 RE: genisi #107437

Re: VRUS/PSI-938

Continued good progress for VRUS in the clinic to be sure. But, how much more upside do we see for the stock at its ~$1.2B market cap, short of a buyout offer? I.e., would a partnership for any of its HCV nukes propel the stock materially higher from the current market cap?